Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data???
- 1 January 1983
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 8 (4), 355-364
- https://doi.org/10.2165/00003088-198308040-00006
Abstract
Previously reported routine Phenytoin clinical pharmacokinetic data from Japan, England, and Germany were analysed to estimate population pharmacokinetic parameters. There were 780 steady-state phenytoin concentrations and associated dosage rates (mg/day) from 322 patients. The patient group spanned paediatric and adult ages, mean age being 18.4 ± 17.3 (SD) years; 53% were males. The data were analysed using NONMEM, a computer programme designed for population pharmacokinetic analysis. Estimates of the influence of age, gender, data source, height and weight on the maximum elimination rate (Vm) and Michaelis-Menten constant (Km) were obtained. The Vm and Km of a 70kg adult male European were estimated to be 415 mg/day and 5.7 mg/L, respectively. Vm is not influenced by gender, age or data source. The parameters of a power function of height and weight were estimated to adjust Vm for body size. The best function adjusts Vm in proportion to weight to the 0.6 power; height contains no useful information. Km is not influenced by gender. The Km for patients less than 15 years old is 43% less than that of older patients. The Km of Japanese patients appears to be 23% less than that for European patients. Even after adjustments for age, etc., apparent Vm and Km vary unpredictably among individuals with a coefficient of variation between 10 to 20%, and approximately 50% respectively.This publication has 19 references indexed in Scilit:
- A formula to estimate the approximate surface area if height and weight be known. 1916.1989
- Ethnic Differences in Drug MetabolismClinical Pharmacokinetics, 1982
- Predicting individual phenytoin dosageJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patientThe Journal of Pediatrics, 1980
- Predicting Phenytoin Dose—A Revised NomogramTherapeutic Drug Monitoring, 1979
- The clinical pharmacokinetics of phenytoinJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Energy metabolism, body size, and problems of scaling.1970
- Diphenylhydantoin And PhenobarbitalAmerican Journal of Diseases of Children, 1964